.jpg "Jacinda C. Abdul-Mutakabbir, PharmD, MPH photo")
Associate Professor of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California, San Diego, La Jolla, CA, United States
Disclosure(s): CSL Seqirus: Advisor/Consultant, Honoraria; GSK: Advisor/Consultant; Shionogi: Advisor/Consultant, Honoraria
Dr. Jacinda Abdul-Mutakabbir (JAM) is an Associate Professor of Clinical Pharmacy and
Researcher at the University of California San Diego in the Skaggs School of Pharmacy and
Pharmaceutical Sciences and the Division of the Black Diaspora and African American Studies.
Her research focuses on antimicrobial resistance and stewardship, where she identifies health
disparities in various infectious diseases to inform targeted interventions for vulnerable
communities. She has published over 70 articles, including several focused on identifying racial
and social vulnerability differences in various infectious disease states, including Clostridium
difficile infection, candidemia, and others. She was recognized as a top scientist under 30 for
her early contributions to antimicrobial resistance research by the European Society of Clinical
Microbiology and Infectious Diseases in 2020. Additionally, the United States Public Health
Services has recognized her dedication to improving public health, as she was the 2017
recipient of the USPHS Outstanding Service Award, and she currently serves as an appointed
member of the CVSH Health Equity National Advisory Board. In 2021, she received the Society
of Infectious Disease Pharmacists (SIDP) Gita Patel Best Practice Award and the Wayne State
University Warrior of Distinction Alumni Award. In 2023, Dr. Abdul-Mutakabbir was named the
recipient of the Infectious Diseases Society of America (IDSA) Clinical Practice Innovation
Award, and in 2024, she received the American College of Clinical Pharmacy (ACCP) New Clinical
Practitioner Award. Most recently, she was appointed editor for Clinical Microbiology Reviews,
an American Society of Microbiology (ASM) Journal. Dr. Abdul-Mutakabbir remains an active
member of several professional organizations, including the American College of Clinical
Pharmacy (ACCP), the American Society for Microbiology (ASM), the Infectious Diseases Society
of America (IDSA), and the Society for Healthcare Epidemiology of America (SHEA).